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SulTlmary 
Psoriasis is a common chronic skin disease mediated by cellular immune mechanisms and char- 
acterized by an intense neutrophil cell infiltrate and proliferative activation of epidermal kerati- 
nocytes. We have previously described the expression of the inducible nitric oxide synthase 
(iNOS) in epidermal keratinocytes of psoriatic skin lesions. In this study, the role of iNOS in 
psoriatic inflammation was explored ex vivo in psoriatic skin biopsies and in vitro in primary 
cultures of human keratinocytes. Messenger RNA for the iNOS enzyme (iNOS mRNA) was 
detected by reverse transcriptase polymerase chain reaction in skin biopsies from patients with 
psoriasis,  but not in skin specimens from patients with atopic eczema or from healthy volun- 
teers.  As  demonstrated  by  in  situ  hybridization  and  immunohistochemistry,  expression  of 
iNOS mlLNA and its  gene product was localized to the epidermal keratinocytes of psoriatic 
skin lesions. In situ hybridization further revealed a complete colocalization of mRNA expres- 
sion for iNOS with interleukin (IL) 8 receptor--specific mRNA either in the basal germinative 
cell layer or at focal sites of ongoing neutrophil inflammation in suprabasal  cell layers. Because 
psoriatic keratinocytes have previously been shown to express mRNA transcripts for IL-8, it 
seemed reasonable to hypothesize that iNOS expression could be induced in an autocrine loop 
by IL-8. This hypothesis was substantiated by our in vitro experiments showing that a combi- 
nation of IL-8 and interferon ~/ induces the expression of iNOS-specific mRNA and of the 
functional enzyme in cultured human keratinocytes. These results suggest an important role for 
iNOS in concert with IL-8 and its receptor early during the formation of psoriatic lesions. 
p psoriasis is a  genetically determined disease  of the  skin 
characterized by two biological hallmarks. First, there is 
profound  epidermal  hyperprohferation  related  to  accel- 
erated and incomplete differentiation.  Second, there is marked 
inflammation  of both  epidermis  and  dermis  with  an  in- 
creased recruitment of cycling T  lymphocytes and forma- 
tion of neutrophil microabscesses (1, 2). Many pathologic 
features of psoriasis  can be attributed to alterations in the 
growth and maturation of epidermal keratinocytes (2). More- 
over, convincing evidence has been accumulated indicating 
that  epidermal keratinocytes are  also  crucial to  cutaneous 
inflammatory and immune responses in psoriasis  by elabo- 
rating various cytokines, adhesion molecules, and chemotactic 
factors, notably IL-8 (3,  4).  The consequences are activa- 
tion of dermal microvascular endothelial cells and selective 
accumulation  of specific  mononuclear  cells  within  focal 
skin areas (4). 
Despite recent advances in the understanding of the skin 
immune  system,  the  regulatory and  effector mechanisms 
underlying epidermal and immunological activation in pso- 
riasis remain incompletely understood. In a previous report 
we  demonstrated expression of the inducible nitric  oxide 
synthase (iNOS) by epidermal keratinocytes and its associa- 
tion with psoriatic skin lesions (5).  iNOS is a P-450-type 
cytoplasmic hemeprotein that catalyzes the conversion of 
L-arginine to L-citmlline and nitric oxide (NO) (6, 7). NO, 
in addition to its role as a cellular messenger at low concen- 
trations, has been shown to play a decisive role in inflam- 
matory and autoimmune tissue  injury because of its cyto- 
toxic and immunoregulatory properties when synthesized 
at  high  concentrations  (7-9).  The  inducible  isoform  of 
NOS is able to produce large amounts of NO and can be 
expressed in a number of mammalian  cells after challenge 
with proinflammatory cytokines, such as  IFN-~/, TNF-ot, 
and IL-I[~ (10,  11).  It seems reasonable, therefore, to sug- 
gest  that  iNOS  expression in  epidermal  keratinocytes of 
psoriasis  might  be  induced by  cytokines present  in  their 
immediate environment. In fact, a complex pattern of cy- 
tokine  expression has  been  demonstrated in  psoriatic  le- 
sions,  including  IFN-~/,  TNF-0~,  I1-113, IL-2,  and  IL-6, 
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tion (2,  4). Most recently, it became evident that IL-8 ap- 
pears to be pivotal in the formation of psoriatic lesions, re- 
sponsible  for  prominent  leukocytic  infiltration  as  well  as 
keratinocyte hyperproliferation (12, 13). In epidermal kera- 
tinocytes  of psoriatic  skin  lesions  we  demonstrated  in- 
creased  expression of IL-8  and  its receptor  (IL-8PQ  (13). 
Furthermore,  we  identified  the  epidermal  IL-8I(  as  the 
molecular target  for  the  immunomodulatory  antipsoriatic 
drug  FK  506  (tacrolimus)  as  well  as  other  antipsoriatic 
agents (14,  15). 
It is currently well established that the cytokine-inducible 
NOS  is involved in  diverse physiologic and pathophysio- 
logic processes, including host immune  defense, immuno- 
regulation,  and  tissue  destruction in  autoimmune  diseases 
(16,  17).  Investigations on its role and expression in com- 
mon skin diseases, however, are lacking. This report dem- 
onstrates  that  mRNA  transcripts  of iNOS,  expressed  by 
epidermal keratinocytes in psoriatic skin lesions, are colo- 
calized with  mI(NA  transcripts  of the  epidermal IL-8P,. 
Moreover,  we  here  show  for the  first time  that  IL-8 is a 
potent costimulatory inducer for iNOS  expression in cul- 
tured human keratinocytes, providing a mechanism to link 
induction  of iNOS  with  the  characteristic neutrophil  in- 
flammation in psoriasis. 
Materials  and Methods 
Selection and Preparation  of Skin Sections 
Fresh keratoma biopsies were taken from lesional and nonle- 
sional skin of 15  patients with untreated, longstanding psoriasis 
and,  for control purposes, from  10 pauents with atoplc eczema 
and 10 healthy volunteers. Skin biopsies were flash frozen in liq- 
uid nitrogen and used for either reverse transcnptase (R.T) PCR, 
in SltU hybridization, or redirect immunohistochemistry. 
Cell Stimulation and Culture 
Cell Culture Reagents.  Complete medium consisted of Kerati- 
nocyte-SFM  (Gibco  Laboratories,  Grand  Island,  NY)  supple- 
mented  with  2.5  ng/ml  epidermal growth  factor,  25  ~g/ml 
bovine pituitary extract, 70 U/ml penicillin, and 70 b~g/ml strep- 
tomycin. Homogeneous rlL-8 was obtained from R.&D Systems 
(Abingdon,  UK).  Recombinant  human  IFN-',/, TNF-o~,  and 
IL-113 were purchased from HBT (Leiden, Netherlands). 
Cell Purification.  Primary epidermal keratinocytes were  pre- 
pared from reduction mammoplasty specimens essentially as de- 
scribed (3). Cells were grown in vitro on plastic substrates  under 
standard culture  conditions.  Primary cultures consisted of pure 
epidermal keratmocytes as also  demonstrated by antlcytokeratln 
immunocytochermstry. 
Cell Stimulation.  For  stimulation  of 1NOS  expression,  pn- 
mary human  keratinocytes were  cultured in Keratinocyte-SFM 
without  epidermal growth  factor and  bovine  pituitary extract. 
Confluent monolayers were incubated for 24 h in the presence or 
absence oflL-8, IFN-~/, TNF-o~, and/or 1L-113. The capacity of 
these cytokines to induce iNOS expression was evaluated using 
R.T-PCR amplification, in situ hybridization, redirect lmmuno- 
cytochernistry, and a colorimetnc nitrite assay to quantify nitrite 
accumulation in the cell culture medium. Experiments were per- 
formed with cells m either their second or third passage in vitro. 
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R T-PCR Analysis 
Freshly harvested epidermal cells or tissues were flash frozen m 
hquid  nitrogen.  Total  RNA  extraction  was  performed  using 
guanichnium tl-nocyanate as described (13). F~rst strand cDNA was 
prepared from 1 ~g of RNA using Avaan moloney leukemia wrus 
reverse tramcriptase  (Boehringer Mannheim, Marmheim, Germany) 
under the conditions suggested by the supplier. After reverse  tran- 
scription, amplification was carried out by PCR using Taq poly- 
merase  (Gibco  Laboratories)  with  15  mM  MgCh.  PCR  was 
performed with primers specific for iNOS  (5'-ATGCCAGAT- 
GGCAGCATCAGA-3'  and  5'-TTTCCAGGCCCATTCTCC- 
TGC-3'), yielding a 394-bp product; and for glyceraldehyde- 
3-phosphate-dehydrogenase (G3DPH; 5'-ACAGTCCATGCCAT- 
CACTGCC-3'  and  5'-GCCTGCTTCACCACCTTCTTG-3') 
to yield a 228-bp product. Cycle times were 30 s at 94°C, 30 s at 
60°C, and 30 s at 72°C for 35 cycles. 20% of the iNOS reaction 
was combined with 5% of the G3PDH reaction and analyzed tbr 
the presence or absence of the 1NOS species by electrophoresxs 
on a 2% agarose gel. 
In Situ Hybridization Studies 
Preparation of Digoxigenin-labeled mRNA Probes.  iNOS  cDNA 
from  mouse  macrophage  was  a  generous  gift  from  Drs.  Carl 
Nathan and Qiao-wen Xle (Cornell Umversity Medical College, 
New York, NY). cDNA of IL-8R type A was kindly provided 
by Dr. William Wood (DNAX Research Institute of Molecular 
and Cellular Biology, Palo Alto, CA). Both DNA probes were 
subcloned in a transcnption vector as previously described (18). 
After linearization of plasmid DNA with appropriate restnctlon 
enzymes, labeled antisense and sense riboprobes were synthesized 
by in vitro transcription of cDNA, cloned downstream of SP6 or 
T7 promoters, with SP6 or T7 RNA polymerase using digoxlge- 
nm-labeled UDP as substrate (Boehringer Mannhelm). 
Hybridization Procedure.  The protocol described by Leltch et al. 
(18) was used with minor alterations. In brief, 7-~m cryostat sec- 
tions  or  cultured  human  keratinocytes  were  hybridized  with 
dlgoxlgenm-labeled antlsense and sense  nboprobes for iNOS or 
IL-8R..  After posthybridizanon high-stringency washing proce- 
dures, slides were incubated with an alkaline phophatase-labeled 
antldigoragenin Ab (Boehringer Mannheim). Visualization of the 
probe hybridization side was performed using 5-bromo-4-chloro- 
3-indolyl phosphate  tolmdine and  mtroblue  tetrazolium salt  as 
chromogemc  enzyme  substrates  (Boehnnger  Mannhexm).  No 
positive  hybndization  signals  were  observed in  any  specimens 
treated with the sense riboprobes. 
Immunohistochemical Analysis Of iNOS Protein 
The immunohistochemical procedures followed methods de- 
scribed previously (5) and were performed on 7-p~m frozen sec- 
tions of keratoma biopsies or cultured human  keratinocytes. A 
mouse  mAb to  macrophage iNOS  (Transduction  Laboratories, 
Lexington, KY)  was  used to assess expression of 1NOS protein. 
For negative controls, the  first  mAb was  either omltted or re- 
placed by an irrelevant isotype-matched reagent. These experi- 
ments consistently yielded negative results. Because it has recently 
been observed that the iNOS Ab may cross-react with the consti- 
tutive NOS proteins (19), serial sections were also stained with a 
polyclonal anti-neuronal antiserum and a monoclonal anti-endo- 
thelial Ab (both from Transductlon Laboratories) to test the spec- 
ificity of the  iNOS  mAb.  None  of these latter Abs resulted in 
staining of epidermal kerafinocytes. 
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Figure 1.  RT-PCR. analysis of keratoma biopsies from patients with 
psoriasis (n =  15), atoplc eczema (n =  10) and from healthy volunteers 
(n =  10). 1LNA extracted from skin samples was reversely transcnbed and 
analyzed by PC1< with primers specific for 1NOS (394 bp; upper lane) and 
G3PDH sequences (228 bp; lower lane). Case numbers are shown above 
the lanes. (A) iNOS mRNA xs present m all keratoma bmps~es from le- 
smnal (L) and in 5 out of 15 nonlesmnal (NL) psonanc skin bmpsles. (B) 
1NOS mRNA is not expressed by epidermal keratinocytes oflesmnal skin 
from patxents with atopm eczema nor (C) in skin specimens from healthy 
volunteers. 
Nitrite Assay 
NO synthesis  in primary cultures of human keratmocytes was 
determined by measuring the accumulation of nitrite  (NO2-),  a 
stable  end product  of NO  metabolism,  using  a modified  Griess 
reaction as described earher (19). 
Results and Discussion 
The  specific  expression  of iNOS  mRNA  ex  vivo  was 
determined in keratoma biopsies from patients with psoria- 
sis  or  atopic  eczema  and  from  healthy  volunteers  using 
tLT-PCP,,  amplification,  iNOS  mR.NA  transcripts  were 
demonstrated  in  all  keratoma  biopsies  (n  =  15)  from  le- 
sional psoriatic skin and in 5 out of 15 of the corresponding 
nonlesional  skin biopsies  (Fig.  1 A).  The  strong signal  for 
iNOS  mR.NA  observed  in  these  nonlesional  skin  speci- 
mens appears to be due to preclinical inflammatory skin al- 
terations.  In  contrast,  all  keratoma  biopsies  of atopic  ec- 
zema (n  =  10) were devoid of any iNOS message, as were 
all skin specimens from healthy volunteers  (n =  10)  (Fig.  1, 
Band  C). 
To  determine  the  localization  of iNOS  mRNA  tran- 
scripts  in  psoriatic  skin  lesions,  in  situ  hybridization  was 
performed using cryostat sections of the same biopsies (n =  5 
for  each  of the  three  groups).  Specific  signals  for  iNOS 
mRNA  were  detected  in  keratinocytes  of the  epidermal 
compartment of psoriatic skin biopsies showing two essen- 
tially different localization patterns.  In two out of five biop- 
sies,  keratinocytes  of the  highly  proliferative  basal  epider- 
mal  layer  yielded  a  strong  and  specific  signal  for  iNOS 
mRNA  located in a bandlike pattern, where the hybridiza- 
tion signal was preferentially observed at the tips of the fete 
ridges  (Fig.  2  A).  In  three  out  of five  lesional  skin  speci- 
mens,  however,  epidermal  keratinocytes  showed  a  focal 
pattern  of expression  in  the  suprabasal  cell  layers,  often 
closely  associated with  focal  clusters  of infiltrating  inflam- 
matory cells  of neutrophil  morphology  (Fig.  2  C).  In  two 
out  of five  nonlesionat  psoriatic  skin  specimens,  abundant 
signals were detected in the basal epidermal layer (Fig. 2 E), 
again suggesting a potential role of iNOS in the early phase 
of tissue inflammation m  psoriasis. 
hnmunohistochemical  staining  of psoriatic  skin  speci- 
mens  (n  =  10)  also  localized  the  iNOS  to  the  epidermal 
keratinocytes.  Identical  to  in  situ  hybridization  patterns, 
keratmocytes that stained for iNOS were rather localized in 
the  basal  epidermal  layer  (Fig.  2  F)  of lesional  or  nonle- 
sional skin, respectively, or were focally clustered at sites of 
ongoing  neutrophil  inflammation  in  suprabasal  cell  layers 
(Fig. 2  G). In contrast, no epidermal iNOS mlLNA or pro- 
tein  was  detected  in  any  of the  skin  specimens  from  pa- 
tients with atopic eczema nor from healthy volunteers  (data 
not shown). 
IL-8  is  known  to  play a  critical  role  in  neutrophil  che- 
motaxis  (12,  13),  and mI<NA transcripts  for  IL-8  or  IL-8R 
and IL-8 immunoreactivity were found either focally clus- 
tered in suprabasal keratinocytes associated with infiltrating 
neutrophils  or confined to basal epidermal keratinocytes of 
psoriatic  skin lesions  (12,  20).  Because we have shown in- 
creased expression of mRNA  transcripts for IL-8 and its re- 
ceptor  in  epidermal  keratinocytes  of psoriasis  using  R.T- 
PCP,.  amplification  (13),  we now analyzed the localization 
of IL-8R-expressing cells in serial sections of the same pso- 
riatic  skin  specimens  using  in  situ  hybridization.  In  com- 
plete  accordance  with  the  expression  pattern  observed  for 
iNOS  gene  expression,  we  found  IL-8R  mRNA  tran- 
scripts to be  colocalized with iNOS  mRNA  transcripts  ei- 
ther  in  the  basal  epidermal  compartment  or  in  the  supra- 
basal cell layers at sites of ongoing neutrophil inflammation 
(Fig.  2,  B  and  D).  The  simultaneous  expression  of both 
iNOS  and IL-8R gene in psoriatic  epidermal keratinocytes 
suggests  a paracrine  and/or  autocrine  pathway involved  in 
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and IL-8tk in skin specimens of  psori- 
asis by m  sxtu hybndazation (A-E) and 
unmunobastochemistry (F and G).  For 
in  SltU  hybridization  experiments, 
blue  staining of the cytoplasm is  in- 
dicative of  cells containing the respec- 
tive  transcripts.  In  lmmunolabehng, 
brown signals are obtained with blue 
nuclei  due  to  hematoxyhn  counter- 
staining. (A) In lesional psonanc skin, 
the  epidermal  keratmocytes  of  the 
highly  proliferative  basal  cell  layer 
yielded a strong and specific signal for 
iNOS in a bandlike hybridization pat- 
tern.  (B)  The locahzanon of mP,  NA 
transcnpts  for IL-8R completely corre- 
sponds to  the  dastnbutmn  of mRNA 
transcripts for iNOS shown an A  (C) 
In a minority oflesmnal psonatac skin 
biopsies,  the  cells  expressing  1NOS 
rnRNA cluster m  suprabasal  cell lay- 
ers.  (D)  In  these specimens, IL-8R- 
specific mRNA as coexpressed in the 
suprabasal  kerannocytes  of psonanc 
epidermis. (E) Strong and specific sig- 
nals for aNOS  mtLNA an  a bandllke 
pattern were  observed an  a  minority 
of nonleslonal skin biopsies obtained 
from psoriatic pauents. Control stud- 
les performed with  sense nboprobes 
for 1NOS  or IL-8R  were  uniformly 
negative.  (F  and  G)  Immunohls- 
tochemlcal localization of 1NOS pro- 
tern m the epidermis oflesional psoriatic skin. Note the prominent staining in the basal epidermal cell layer (F) or at sites of ongoing neutrophil inflam- 
mation (G). Senal secuons were also stained for ecNOS or ncNOS, which dad not label keratlnocytes. 
local  leukocyte  recruitment  as  well  as  keratinocyte  activa- 
tion. 
Earlier  studies  have  shown  that  the  iNOS  gene  can  be 
stimulated  in  a  number  of mammalian  cells by  proinflam- 
matory  cytokines,  notably  IFN-y,  TNF-ot,  and  IL-113  (10, 
11).  A  direct  interaction,  however,  between  iNOS  gene 
expression and the cytokines known  to be involved in pso- 
riatic  inflammation  (2,  20)  has  not  yet been  demonstrated 
for  primary  human  keratinocytes.  To  examine  whether 
epidermal  keratinocytes  can  be  induced  to  express  iNOS 
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Figure 3.  1LT-PCtL detection of 1NOS n'flLNA in resident (~) or cy- 
tokme-challanged  (lanes  A-G)  cultured  human  keratlnocytes.  Pnmary 
keratlnocytes were  incubated for 24  h  with  10  n/Vl IL-8,  1,000  U/ml 
IFN-"/, 1,000 U/ml TNF-cx, and 1,000  U/ml IL-113 alone or in combi- 
nations indicated. None of these cytoklnes was effective as a single agent 
(lanes A-D), nor was the combinanon oflFN-y plus IL-113 (lane  E)  In 
contrast, the combined exposure to IL-8 plus IFN-'y (lane  F)  or TNF-cl 
plus  IL-113 (lane  G)  resulted  m  a  strong  positive  signal.  No  iNOS 
mRNA, however, was detected m  resident epidermal keratmocytes ('Jr) 
Numbers mdacate the relative positrons of  the molecular weight standards. 
Figure 4.  In sltu hybndazanon for aNOS mtLNA in resident or cyto- 
kme-challenged human keratmocyte cultures. (A) No Induction of iNOS 
mRNA  in  resident  keratxnocytes.  (B)  Strong  hybridlzanon  signal  for 
1NOS mRNA was detected in epidermal kerannocytes after 24-h incuba- 
tion with 10 nM IL-8 plus 1,000  U/nil IFN-'y. 
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Figure  5.  N~tnte production by cytokme-challenged human kerati- 
nocyte cultures. Primary human keratlnocytes were cultured m the pres- 
ence or absence of 10 nM IL-8, 1,000 U/ml IFN-y, 1,000 U/ml TNF-0t, 
and 1,000 U/ml I1-113. After 24 h ofincubanon, mtrlte production in the 
culture me&a was  deternnned spectrophotometncally by  a modified 
Gness reacnon, and the presented results are the mean +_. SD of three ex- 
periments performed in duplicate. 
by  signals  present  in  a  psoriatic  microenvironment,  we 
treated cultured normal human keratinocytes with IL-8, ei- 
ther alone or in combination with IFN-3,, TNF-ot, or IL-113. 
Whereas none of these cytokines was active when added as 
single  components,  IL-8  (10  nM)  in  combination  with 
IFN-y  (1,000 U/ml)  resulted in iNOS mlLNA expression 
in  human  keratinocytes  as  detected by  ILT-PCP,.  (Fig.  3, 
lanes A-D  and F) and in situ hybridization (Fig. 4 B). The 
translation into protein was verified by immunocytochem- 
istry  (data  not shown).  The  combination  of TNF-ci  with 
IL-113 was  also  found  to  be  effective  in  inducing  iNOS 
mP,.NA  (Fig.  3,  lane  G)  or  protein,  whereas  IFN-y  in 
combination with TNF-0t or IL-113 (Fig. 3, lane E) proved 
to be ineffective.  Priming of keratinocytes with IFN-y for 
24 h followed by stimulation with IL-8, TNF-0t, or IL-113 
also  failed  to  induce  iNOS  expression  in  cultured  human 
keratinocytes  (data  not  shown).  Neither  iNOS-specific 
mRNA (Fig. 3 "i', and Fig. 4 A) nor its gene product were 
detected  in  unchallenged keratmocytes.  Nitrite  accumula- 
tion in the cell  culture media was found to exactly parallel 
the response profiles seen with iNOS mlLNA and protein 
detection methods (Fig.  5). Increased nitrite formation was 
not detected in the presence of 0.5 mM/Va-monomethyl  - 
r-arginine,  These  findings introduce  iNOS  as a molecular 
signal  present  in  the  inflammatory  response  of epidermal 
keratinocytes and extend our previous efforts to unravel the 
molecular pathophysiology of inflammation in psoriasis. 
Moreover,  our studies  establish  a  unique  profile  of cy- 
tokine responsiveness in human keratinocytes, because iNOS 
expression could only be induced by synergistic combina- 
tions of IL-8 plus IFN-~/or TNF-ot plus IL-1[3.  This pro- 
file for NOS induction clearly distinguishes human kerati- 
nocytes from other cells and tissues in which inducibility is 
also conferred by single activators or other cytokine combi- 
nations.  Thus,  expression  of  iNOS  in  human  hepato- 
cytes--of epithelial  cell origin also--is  known to be  con- 
trolled  at  the  level  of transcription  by  IL-113 alone  or  in 
combination with IFN-',/(8), which is ineffective m kerati- 
nocytes.  The  observation of iNOS  expression  in psoriatic 
but  not  in  atopic  skin  specimens  demonstrates  a  key role 
for the local cytokine profile an the regulation of iNOS ex- 
pression m vivo. 
Our contention that iNOS is involved in the pathogene- 
sis of psoriasis is further supported by the antiinflammatory 
effects of retinoids in the treatment of psoriasis, which have 
been  shown to inhibit iNOS gene transcription (21). 
In this study we provide the first experimental evidence 
that  IL-8,  which  is  a  potent  chemotactic  agent  for  both 
neutrophils  and  T  lymphocytes  at  nanomolar  concentra- 
tions  (14),  is  of central importance for keratinocyte iNOS 
gene  expression.  The fact that IL-8 induces iNOS  expres- 
sion  only  in  combination  with  T  lymphocyte-derived 
IFN-~/  corresponds  to  the finding that  T  lymphocytes in- 
volved in psoriasis belong to the Thl  subset producing the 
proinflammatory cytokines IFN-y and  IL-2  (22).  In  sum- 
mary, our results support the idea that the role of IL-8 and 
its  receptor  in  psoriasis  is  not limited to proinflammatory 
and neutrophil-attracting functions, but that IL-8 in  com- 
bination with IFN-'y also  acts  as an autocrine or paracrine 
immunomodulator by eliciting the NO pathway. A previ- 
ous report showed IL-8-mediated downregtflation of iNOS 
expression in neutrophils (23), which may be an indication 
of  different  gene  expression  regulations  in  different  cell 
types. We also found the combinanon of TNF-o~ and IL-1[3 
as  a potent inducer  of iNOS  expression.  Because  TNF-ci 
and IL-113 have been shown to enhance IL-8 release from 
human  keratinocytes  (20),  iNOS  expression  in  keratino- 
cytes may result via a common IL-8 pathway. 
It is tempting to further speculate that iNOS  expression 
in psoriatac lesions is involved in the alterations  of epider- 
mal  proliferation  and  differentiation,  because  in  neuronal 
cells the induction of iNOS is an important step in the ar- 
rest of cell proliferation and initiates the switch to terminal 
differentiation  (24).  Moreover,  NO-mediated  activation 
of the soluble heme-containing guanylate cyclase is known 
to result in increased intracellular levels of cGMP, a known 
regulator  of cell  growth  and  differentiation.  Indeed,  in- 
creased  cGMP  levels  are  found  in  psoriatic  skin  lesions 
and therefore may be causally related to iNOS gene expres- 
sion (25). 
2011  Bruch-Gerharz et al.  Brief Definitive Report Further eluctdation of the molecular signals involved in 
the  regulatory and effector  mechanisms of iNOS  expres- 
sion in epidermal keratinocytes may give insights into the 
pathogenesis of psoriasis. Modulation of iNOS  expression 
could provide a therapeutic aim in psoriasis and other im- 
mune-mediated skin diseases. 
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